Cargando…
Clinical and Immunological Outcomes in High-Risk Resected Melanoma Patients Receiving Peptide-Based Vaccination and Interferon Alpha, With or Without Dacarbazine Preconditioning: A Phase II Study
Clinical studies based on novel rationales and mechanisms of action of chemotherapy agents and cytokines can contribute to the development of new concepts and strategies of antitumor combination therapies. In previous studies, we investigated the paradoxical immunostimulating effects of some chemoth...
Autores principales: | Urbani, Francesca, Ferraresi, Virginia, Capone, Imerio, Macchia, Iole, Palermo, Belinda, Nuzzo, Carmen, Torsello, Angela, Pezzotti, Patrizio, Giannarelli, Diana, Pozzi, Anna Fausta, Santaquilani, Mariano, Roazzi, Paolo, Bastucci, Silvia, Catricalà, Caterina, La Malfa, Antonia, Vercillo, Giuseppe, Gualtieri, Novella, Buccione, Carla, Castiello, Luciano, Cognetti, Francesco, Nisticò, Paola, Belardelli, Filippo, Moschella, Federica, Proietti, Enrico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069350/ https://www.ncbi.nlm.nih.gov/pubmed/32211314 http://dx.doi.org/10.3389/fonc.2020.00202 |
Ejemplares similares
-
Blood immune cells as potential biomarkers predicting relapse-free survival of stage III/IV resected melanoma patients treated with peptide-based vaccination and interferon-alpha
por: Moschella, Federica, et al.
Publicado: (2023) -
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma
por: Rozera, Carmela, et al.
Publicado: (2015) -
Type I Interferons and Cancer: An Evolving Story Demanding Novel Clinical Applications
por: Aricò, Eleonora, et al.
Publicado: (2019) -
Polyfunctional Melan-A-specific tumor-reactive CD8(+) T cells elicited by dacarbazine treatment before peptide-vaccination depends on AKT activation sustained by ICOS
por: Franzese, Ornella, et al.
Publicado: (2016) -
Immune Monitoring in Cancer Vaccine Clinical Trials: Critical Issues of Functional Flow Cytometry-Based Assays
por: Macchia, Iole, et al.
Publicado: (2013)